Clinical trial
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
NCT05337124 is registered in ClinicalTrials.gov with Aurinia Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
- Lead sponsor
- Aurinia Pharmaceuticals Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 5, 2022
- Completion date
- January 31, 2025
- Enrollment
- 229 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.